SCHEMBL2199563

SCHEMBL2199563

C=C(C=O)c1ccc2c(c1)CCCN2c1ccc2c(c1)C(C)(C)c1ccccc1-2

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.41
OPRM1 P35372 18/20 0.39
OPRK1 P41145 18/20 0.39
OPRD1 P41143 17/20 0.39
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2200992 0.84 ALDH1A1 (0.48) PDK2OPRM1OPRK1OPRD1
SCHEMBL2199560 0.80 PDK2 (0.39) PDK2OPRM1OPRK1OPRD1
SCHEMBL2199557 0.80 PDK2 (0.39) PDK2OPRM1OPRK1OPRD1
SCHEMBL12305838 0.78 OPRM1 (0.36) PDK2OPRM1OPRK1OPRD1ACHE
SCHEMBL12305827 0.76 PDK2 (0.38) PDK2
SCHEMBL12305910 0.72 ACHE (0.33) PDK2OPRM1OPRK1OPRD1ACHE
SCHEMBL12428140 0.71 KAT8 (0.37) PDK2
SCHEMBL2197711 0.71 PRF1 (0.43) PDK2
SCHEMBL13365967 0.71 EED (0.38) PDK2OPRM1
SCHEMBL13304048 0.70 PDK2 (0.36) PDK2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
EP-1885015-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 PDK2 1511/4885OPRM1 1218/4885OPRK1 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.